Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.34 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.34 |
| ▸ | GLP1R | P43220 | 8/20 | 0.34 |
| ▸ | GNPAT | O15228 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | ALB | P02768 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20235586 | 0.91 | FAAH (0.36) | FOLH1EPHX2NOD1GLP1RGNPAT | |
| SCHEMBL16231542 | 0.90 | FOLH1 (0.38) | FOLH1EPHX2NOD1GLP1RGNPAT | |
| SCHEMBL16231541 | 0.86 | FOLH1 (0.40) | FOLH1EPHX2NOD1GLP1RGNPAT | |
| SCHEMBL20235728 | 0.83 | F2 (0.36) | FOLH1EPHX2NOD1GLP1RPTPN1 | |
| SCHEMBL20235702 | 0.83 | FOLH1 (0.41) | FOLH1EPHX2NOD1GLP1RGNPAT | |
| SCHEMBL16231538 | 0.80 | GLP1R (0.35) | FOLH1EPHX2NOD1GLP1RPTPN1 | |
| SCHEMBL20235803 | 0.80 | FOLH1 (0.38) | FOLH1EPHX2NOD1GLP1RGNPAT | |
| SCHEMBL20235724 | 0.80 | FOLH1 (0.33) | FOLH1EPHX2NOD1GLP1RGNPAT | |
| SCHEMBL20235730 | 0.79 | FOLH1 (0.44) | FOLH1EPHX2NOD1GLP1RGNPAT | |
| SCHEMBL25517376 | 0.78 | GNPAT (0.43) | FOLH1EPHX2NOD1GLP1RGNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10626438-B2 | Fluorescent substrates for determining lysine modifying enzyme activity | THE BROAD INSTITUTE, INC. (US) | 2020-04-21 | — | — | US | disclosed |
| US-20180155760-A1 | FLUORESCENT SUBSTRATES FOR DETERMINING LYSINE MODIFYING ENZYME ACTIVITY | BROAD INST INC (US) | 2018-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180155760-A1 | FLUORESCENT SUBSTRATES FOR DETERMINING LYSINE MODIFYING ENZYME ACTIVITY | KDM1A, MAN2B1, KDM3A | FOLH1 814/4885EPHX2 1831/4885NOD1 2430/4885 |
| US-10626438-B2 | Fluorescent substrates for determining lysine modifying enzyme activity | KDM1A, MAN2B1, KDM3A | FOLH1 814/4885EPHX2 1831/4885NOD1 2430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.